{"id":462805,"date":"2010-03-23T14:25:11","date_gmt":"2010-03-23T18:25:11","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=69883"},"modified":"2010-03-23T14:25:11","modified_gmt":"2010-03-23T18:25:11","slug":"smartcells-grabs-1-75m","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/462805","title":{"rendered":"SmartCells Grabs $1.75M"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/funding\/\">funding<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/deals\/\">deals<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/Biotech\/\">Biotech<\/a><\/div>\n<p>\t\t<strong>Erin Kutz wrote:<\/strong><\/p>\n<p><a href=\"http:\/\/www.smartinsulin.com\/index.html\">SmartCells<\/a>, a Beverly, MA-based company developing a daily, self-regulating injection for treating diabetes, has raised $1.75 million of a planned $4 million equity offering, according to an SEC <a href=\"http:\/\/www.sec.gov\/Archives\/edgar\/data\/1304807\/000130480710000001\/xslFormDX01\/primary_doc.xml\">filing<\/a>. The company, whose SmartInsulin product is in pre-clinical testing, declined to comment at this time on what round the funding represents. In July, SmartCells completed the sale of $1.15 million in convertible debt, according to the company <a href=\"http:\/\/www.smartinsulin.com\/news\/news_main.html\">website<\/a>.<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/boston\/2010\/03\/23\/smartcells-grabs-1-75m\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20SmartCells%20Grabs%20$1.75M%20http:\/\/xconomy.com\/?p=69883\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/boston\/2010\/03\/23\/smartcells-grabs-1-75m\/&#038;t=SmartCells%20Grabs%20$1.75M\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/boston\/2010\/03\/23\/smartcells-grabs-1-75m\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=SmartCells+Grabs+%241.75M&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fboston%2F2010%2F03%2F23%2Fsmartcells-grabs-1-75m%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>\t     \t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=36d97eab3c14ae6e2fff5de6a5ff43d5&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=36d97eab3c14ae6e2fff5de6a5ff43d5&#038;p=1\"\/><\/a><br \/>\n<!-- foo --><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/OmcPgBt-25B96iyHla6hMLhWGlk\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/OmcPgBt-25B96iyHla6hMLhWGlk\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/OmcPgBt-25B96iyHla6hMLhWGlk\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/OmcPgBt-25B96iyHla6hMLhWGlk\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/y1nNPlyzg3o\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>funding, deals, Biotech Erin Kutz wrote: SmartCells, a Beverly, MA-based company developing a daily, self-regulating injection for treating diabetes, has raised $1.75 million of a planned $4 million equity offering, according to an SEC filing. The company, whose SmartInsulin product is in pre-clinical testing, declined to comment at this time on what round the funding [&hellip;]<\/p>\n","protected":false},"author":1661,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-462805","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/462805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1661"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=462805"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/462805\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=462805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=462805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=462805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}